During this interactive and engaging activity, we will focus on addressing the role of omega-3 fatty acids in treating patients with or at high risk of atherosclerotic cardiovascular disease (ASCVD) using the most recent evidence and guideline recommendations.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Omega-3 Fatty Acids and ASCVD
What’s the role of omega-3 fatty acids in treating patients with or at high risk of atherosclerotic cardiovascular disease (ASCVD)?
Live
Broadcast
Information
May 14, 2020
07:00 PM - 08:00 PM EDT
Online
Share this program on:
Choose a format
Details
Presenters
Related
Comments
Overview
Program Schedule
Welcome, Introductions, Program Overview
Dave L. Dixon, PharmD - Chair15 minutes
Clinical Trial Evidence of Omega-3 Fatty Acids in ASCVD
Joseph Saseen, PharmD15 minutes
Comparisons of Omega-3 Fatty Acid Products
Daniel E. Hilleman, PharmD15 minutes
Clinical Utility of Adjunct Therapies to Statins for ASCVD Event Reduction
Dave L. Dixon, PharmD - Chair15 minutes
Discussion, Questions and Answers
All FacultyClosing Comments, Adjourn
Dave L. Dixon, PharmD - Chairtbd
Learning Objectives
At the conclusion of this activity, learners should be better able to:
- Describe the spectrum of large-scale omega-3 fatty acids on ASCVD outcomes trials
- Recognize the difference between omega-3 fatty acids and their formulations to impact ASCVD events, including the negative role of dietary supplements
- Use information on clinical utility of adjuncts to statin therapy to improve management of patients with or at high risk of ASCVD events
Target Audience
This activity is designed to meet the educational needs of retail, hospital and managed care pharmacists.
Accreditation and Credit Designation Statements
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0430-9999-20-002-L01-P
Credits: 1.0 (0.10 CEU) for this CE activity
Type of Activity: ApplicationCommercial Support
This activity is supported by an independent educational grant from Amarin Pharma, Inc.
Presenters
Details
Presenters
Related
Comments
Recommended
Overview
During this interactive and engaging activity, we will focus on addressing the role of omega-3 fatty acids in treating patients with or at high risk of atherosclerotic cardiovascular disease (ASCVD) using the most recent evidence and guideline recommendations.
Program Schedule
Welcome, Introductions, Program Overview
Dave L. Dixon, PharmD - Chair15 minutes
Clinical Trial Evidence of Omega-3 Fatty Acids in ASCVD
Joseph Saseen, PharmD15 minutes
Comparisons of Omega-3 Fatty Acid Products
Daniel E. Hilleman, PharmD15 minutes
Clinical Utility of Adjunct Therapies to Statins for ASCVD Event Reduction
Dave L. Dixon, PharmD - Chair15 minutes
Discussion, Questions and Answers
All FacultyClosing Comments, Adjourn
Dave L. Dixon, PharmD - Chairtbd
Learning Objectives
At the conclusion of this activity, learners should be better able to:
- Describe the spectrum of large-scale omega-3 fatty acids on ASCVD outcomes trials
- Recognize the difference between omega-3 fatty acids and their formulations to impact ASCVD events, including the negative role of dietary supplements
- Use information on clinical utility of adjuncts to statin therapy to improve management of patients with or at high risk of ASCVD events
Target Audience
This activity is designed to meet the educational needs of retail, hospital and managed care pharmacists.
Accreditation and Credit Designation Statements
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0430-9999-20-002-L01-P
Credits: 1.0 (0.10 CEU) for this CE activity
Type of Activity: ApplicationCommercial Support
This activity is supported by an independent educational grant from Amarin Pharma, Inc.
Presenters
Facebook Comments
Recommended
Title
Share on ReachMD
Close
Programs 2/27/21
Facebook Comments